1 study found for:    6790275 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures
Condition: Epilepsy
Interventions: Drug: Retigabine 900mg/day;   Drug: Retigabine 600mg/day;   Other: Placebo

Indicates status has not been verified in more than two years